Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Orlando Adolfo Lovelle"'
Publikováno v:
Edumecentro, Vol 13, Iss 4, Pp 274-287 (2021)
Introducción: la enfermedad por SARS-Cov-2 refuerza la importancia del uso de las nuevas tecnologías de la información y las comunicaciones en función del desarrollo e implementación de sistemas de inteligencia artificial que favorecen el diagn
Externí odkaz:
https://doaj.org/article/85ab07bceb544e279cb32efd4ff9bf9e
Autor:
Orlando Adolfo Lovelle Enriquez, Wilfredo de Jesús Machín Cabrera, Marlen Pérez Diaz, Miguel Ángel Rodríguez Allende
Publikováno v:
Revista Cubana de Medicina Militar, Vol 50, Iss 3, Pp e02101381-e02101381 (2021)
Introduction: Since the emergence of the first cases of COVID-19 pandemic, a dizzying race has developed in creating a research space for the diagnosis, treatment and control of the disease. Objective: To describe the clinical and radiological charac
Externí odkaz:
https://doaj.org/article/2299347726954e2e8391c379d190a300
Autor:
Yaumara Aguilera Calzadilla, Yayquier Diaz Morales, Leonardo Abilio Ortiz Díaz, Olga Linee Gonzalez Martínez, Orlando Adolfo Lovelle Enríquez, Maria de Lourdes Sánchez Álvarez
Publikováno v:
Revista Cubana de Medicina Militar, Vol 49, Iss 3, Pp e0200793-e0200793 (2020)
Introduction: The first reports from China suggested that coinfection with other pathogens in COVID-19 was abnormal, the latest evidence has shown that other infections may appear, especially in severe patients. Objective: To describe the bacterial i
Externí odkaz:
https://doaj.org/article/7575a52578f4477793c98c31363aee9e
Publikováno v:
Medicentro, Vol 21, Iss 3, Pp 278-281 (2017)
El infarto talámicoparamediano bilateral sincrónico, llamado habitualmente infarto de la arteria de Percheron, se considera infrecuente y de difícil diagnóstico clínico. Se presenta a una paciente de 50 años, con infarto talámico bilateral, qu
Externí odkaz:
https://doaj.org/article/0cda03ec86224605a607edf5303a611a
Autor:
Kalet León, Danay Saavedra, Armando Caballero, Jorge Alain Caballero, Zaima Mazorra, Carlos Figueredo, Ana Laura Añe-Kouri, Naivy Sánchez, Carlos Herrera, Lázaro Manuel Filgueira, Julio Betancourt Cervantes, Mayra Ramos, Geidy Lorenzo, Jorge Berrio, Meylan Cepeda, Orlando Adolfo Lovelle, Tania Crombet
Publikováno v:
Immunotherapy
In COVID-19, the inflammatory cytokine-release syndrome is associated with the progression of the disease. Itolizumab is a monoclonal antibody that recognizes human CD6 expressed in activated T cells. The antibody has shown to be safe and efficacious
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6225684e2389cf8de5c2ffe1d3bad65e
https://doi.org/10.2217/imt-2020-0235
https://doi.org/10.2217/imt-2020-0235